AG
TARO

Aperio Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Aperio Group’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$539K Sell
7,344
-582
-7% -$37.4K ﹤0.01% 1934
2020
Q3 		$435K Sell
7,926
-2,881
-27% -$179K ﹤0.01% 1886
2020
Q2 		$719K Sell
10,807
-3,405
-24% -$228K ﹤0.01% 1578
2020
Q1 		$870K Buy
14,212
+4,932
+53% +$365K ﹤0.01% 1369
2019
Q4 		$816K Sell
9,280
-7,842
-46% -$661K ﹤0.01% 1546
2019
Q3 		$1.29M Sell
17,122
-828
-5% -$67.2K 0.01% 1264
2019
Q2 		$1.53M Sell
17,950
-99
-0.5% -$9.79K 0.01% 1194
2019
Q1 		$1.95M Sell
18,049
-1,331
-7% -$133K 0.01% 1048
2018
Q4 		$1.64M Sell
19,380
-2,517
-11% -$243K 0.01% 1066
2018
Q3 		$2.15M Buy
21,897
+2,631
+14% +$285K 0.01% 1030
2018
Q2 		$2.23M Sell
19,266
-6,757
-26% -$742K 0.01% 980
2018
Q1 		$2.57M Sell
26,023
-29,243
-53% -$2.96M 0.01% 893
2017
Q4 		$5.79M Buy
55,266
+3,300
+6% +$363K 0.03% 586
2017
Q3 		$5.86M Buy
51,966
+1,140
+2% +$124K 0.03% 549
2017
Q2 		$5.7M Buy
50,826
+16,233
+47% +$1.83M 0.03% 538
2017
Q1 		$4.03M Buy
34,593
+14,746
+74% +$1.63M 0.03% 633
2016
Q4 		$2.09M Sell
19,847
-27,219
-58% -$2.85M 0.02% 806
2016
Q3 		$5.2M Sell
47,066
-3,954
-8% -$524K 0.04% 521
2016
Q2 		$7.43M Buy
51,020
+42,632
+508% +$6.05M 0.06% 373
2016
Q1 		$1.2M Buy
8,388
+6,421
+326% +$912K 0.01% 963
2015
Q4 		$304K Buy
+1,967
New +$287K ﹤0.01% 1615

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Aperio Group's TARO Position: Q4 2020 in Review

Aperio Group reduced its Taro Pharmaceutical Industries Ltd. (TARO) stake by 7.3% in Q4 2020, selling an estimated $37.4K and leaving 7,344 shares worth $539K. The position accounts for ﹤0.01% of the portfolio, ranked #1934.

Aperio Group first reported a position in TARO in Q4 2015 and has held it in 21 quarters since. The position peaked at $7.43M in Q2 2016. 84 funds tracked by Wall St. Rank hold TARO as of Q4 2020.

  • Aperio Group held 7,344 shares of Taro Pharmaceutical Industries Ltd. worth $539K as of Q4 2020.
  • Aperio Group sold 582 Taro Pharmaceutical Industries Ltd. shares in Q4 2020, an estimated $37.4K.
  • Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1934 holding.
  • Aperio Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and has held it in 21 quarters since.
  • Aperio Group's Taro Pharmaceutical Industries Ltd. position peaked at $7.43M in Q2 2016.
  • 84 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.